Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
January 30 2023 - 7:01AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of January 2023
Commission File Number: 001-39633
Abcam plc
(Translation
of registrants name into English)
Discovery
Drive
Cambridge Biomedical Campus
Cambridge, CB2 0AX
United Kingdom
(Address
of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On January 30, 2023, Abcam plc (the Company) issued an announcement (the Announcement) of an unaudited
trading update ahead of its results for the 12-month period ended December 31, 2022. The Announcement is furnished herewith as Exhibit 99.1 to this Report on
Form 6-K.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
ABCAM PLC |
|
|
|
Date: January 30, 2023 |
|
By: |
|
/s/ Alan Hirzel |
|
|
|
|
Name: |
|
Alan Hirzel |
|
|
|
|
Title: |
|
Chief Executive Officer |
Abcam (CE) (USOTC:ABCZF)
Historical Stock Chart
From Dec 2024 to Jan 2025
Abcam (CE) (USOTC:ABCZF)
Historical Stock Chart
From Jan 2024 to Jan 2025